Correction to: "Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial"

J Clin Endocrinol Metab. 2025 Feb 4:dgaf048. doi: 10.1210/clinem/dgaf048. Online ahead of print.
No abstract available

Publication types

  • Published Erratum